Machinery & Materials
Logistics & Cold Chain
More from ARTES Biotechnology
ARTES Biotechnology and Bio Farma announce collaboration in vaccine development
ARTES and Bio Farma announced today to join forces for the development and manufacturing of vaccine candidates.
Jul 15th, 2013
ARTES Steps Further Into the Vaccine Business by Acquiring Anavax
ARTES Biotechnology announced the acquirement of the ANAVAX virus-like particle (VLP) technology from Select Vaccines Ltd. ANAVAX is a patent-protected VLP technology that can be applied to the prevention of several infectious diseases.
Oct 1st, 2010